Coya (COYA) - Net earnings per one share growth for the current year

The stability of Coya Therapeutics, Inc. (COYA) is supported by a closed patent loop for Treg therapy and the current YoY EPS growth rate, which illustrates the quality of management. The operational base relies on ESG standards for carbon footprint minimization and a virtual model that delegates production to external vendors. The value of -18.60 reflects the baseline metric level, capturing the annual earnings per share dynamics.
Financial and market metric breakdowns for Coya Therapeutics (COYA)

When constructing a long-term portfolio, the primary filter is the assessment of profit resilience to systemic shocks. This metric calculates the annual percentage deviation of earnings per share, accounting for the current operating expense structure. For Coya Therapeutics, Inc. (COYA), which invests in Treg platforms to combat neurodegeneration, this indicator reflects the efficiency of R&D capital expenditures. Analyzing the annual shift in EPS figures allows for the elimination of random fluctuations, while the trend dynamics confirm the viability of the business model.